Ernie Green Industries and Gilero have made the strategic decision to end their equity partnership, known as EG-GILERO, allowing each company to refocus on their respective core offerings. Going forward, Gilero and Ernie Green Industries will operate as fully independent entities.
 
Gilero will concentrate solely on the medical device and drug delivery markets, offering full end-to-end services in design, development, regulatory, testing, tooling, molding, and manufacturing of finished devices. Ernie Green Industries will continue to focus on its core business of tooling, molding, and contract manufacturing operations such as automation and assembly across several key industries, including medical, consumer, industrial, and automotive.
 
"Ernie Green Industries has experienced dynamic growth over the last 40 years and as we enter the next phase in our history as a global company, we intend to strengthen our focus on our strategic markets and core competencies," said Vinc Ellerbrock, CEO of Ernie Green Industries. "While we look forward to continuing to work with Gilero, we're also very excited about the future of our medical device manufacturing business and providing our customers complete solutions for highly challenging applications. We anticipate continuing to invest to sustain our growth through industry-leading innovations in our advanced engineering and tooling center, as well as specific areas of our molding operations," he added.
 
Ted Mosler, CEO of Gilero, remarked, "It's been a pleasure to grow our business alongside EG Industries. We're thrilled to be building and expanding our capabilities specific to the development and manufacturing of medical and drug delivery devices. Gilero will continue to provide the high level of service our customers have come to expect as we continue to grow our offerings as a trusted partner for medical and drug delivery programs from start to finish."